These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


215 related items for PubMed ID: 20479948

  • 1. Simultaneous treatment to attain blood pressure and lipid goals and reduced CV risk burden using amlodipine/atorvastatin single-pill therapy in treated hypertensive participants in a randomized controlled trial.
    Grimm R, Malik M, Yunis C, Sutradhar S, Kursun A, TOGETHER Investigators.
    Vasc Health Risk Manag; 2010 May 06; 6():261-71. PubMed ID: 20479948
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Amlodipine/Atorvastatin: a review of its use in the treatment of hypertension and dyslipidaemia and the prevention of cardiovascular disease.
    Curran MP.
    Drugs; 2010 May 06; 70(2):191-213. PubMed ID: 20108992
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Single-pill therapy in the treatment of concomitant hypertension and dyslipidemia (the amlodipine/atorvastatin gemini study).
    Blank R, LaSalle J, Reeves R, Maroni J, Tarasenko L, Sun F.
    J Clin Hypertens (Greenwich); 2005 May 06; 7(5):264-73. PubMed ID: 15886529
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia: results of the AVALON trial.
    Messerli FH, Bakris GL, Ferrera D, Houston MC, Petrella RJ, Flack JM, Sun W, Lee E, Neutel JM, AVALON Investigators.
    J Clin Hypertens (Greenwich); 2006 Aug 06; 8(8):571-81; quiz 582-3. PubMed ID: 16896273
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A randomized, placebo-controlled trial to evaluate the efficacy, safety, and pharmacodynamic interaction of coadministered amlodipine and atorvastatin in 1660 patients with concomitant hypertension and dyslipidemia: the respond trial.
    Preston RA, Harvey P, Herfert O, Dykstra G, Jukema JW, Sun F, Gillen D.
    J Clin Pharmacol; 2007 Dec 06; 47(12):1555-69. PubMed ID: 18048574
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of fix dose combination (atorvastatin and amlodipine) in treatment of uncontrolled hypertension and dyslipidemia.
    Bashir S, Sherwani MU, Shabbir I, Batool A.
    J Ayub Med Coll Abbottabad; 2011 Dec 06; 23(3):97-100. PubMed ID: 23272446
    [Abstract] [Full Text] [Related]

  • 16. Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program).
    Hobbs FD, Gensini G, Mancini GB, Manolis AJ, Bauer B, Böhler S, Genest J, Feldman R, Harvey P, Jenssen TG, Metcalfe M, da Silva PM, JEWEL Study Group.
    Int J Cardiol; 2006 Jun 16; 110(2):242-50. PubMed ID: 16338012
    [Abstract] [Full Text] [Related]

  • 17. EFFICACY AND SAFETY OF A SINGLE-PILL COMBINATION OF ATORVASTATIN/AMLODIPINE IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA.
    Naydenov Naydenov S, Margaritov Runev N, Ivanov Manov E, Georgieva Torbova-Gigova S.
    Acta Clin Croat; 2018 Sep 16; 57(3):464-472. PubMed ID: 31168179
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
    Lee IT, Hung YJ, Chen JF, Wang CY, Lee WJ, Sheu WH.
    Clin Ther; 2012 Aug 16; 34(8):1735-50. PubMed ID: 22784975
    [Abstract] [Full Text] [Related]

  • 19. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
    Hussein MA, Chapman RH, Benner JS, Tang SS, Solomon HA, Joyce A, Foody JM.
    Am J Cardiovasc Drugs; 2010 Aug 16; 10(3):193-202. PubMed ID: 20387911
    [Abstract] [Full Text] [Related]

  • 20. Reaching recommended lipid and blood pressure targets with amlodipine/atorvastatin combination in patients with coronary heart disease.
    Dorval JF, Anderson T, Buithieu J, Chan S, Hutchison S, Huynh T, Jobin J, Lonn E, Poirier P, Title L, Walling A, Tran T, Boudreau G, Charbonneau F, Genest J.
    Am J Cardiol; 2005 Jan 15; 95(2):249-53. PubMed ID: 15642561
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.